Progyny stock hits 52-week high at 31.07 USD
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Progyny Inc (PGNY)
Progyny Inc stock price live, this page displays NASDAQ PGNY stock exchange data. View the PGNY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Progyny Inc real time stock price chart below.
What Is the Progyny Inc Stock Price Today?
The Progyny Inc stock price today is 30.65.
What Is the Stock Symbol for Progyny Inc?
The stock symbol for Progyny Inc is "PGNY."
What Stock Exchange Does Progyny Inc Trade On?
Progyny Inc is listed and trades on the NASDAQ stock exchange.
Is Progyny Inc a Good Stock to Buy?
Determining whether Progyny Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PGNY quote. (ISIN: US74340E1038)
What Is the Progyny Inc Stock Price Today?
The Progyny Inc stock price today is 30.65.
What Is the Stock Symbol for Progyny Inc?
The stock symbol for Progyny Inc is "PGNY."
What Stock Exchange Does Progyny Inc Trade On?
Progyny Inc is listed and trades on the NASDAQ stock exchange.
Is Progyny Inc a Good Stock to Buy?
Determining whether Progyny Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PGNY quote. (ISIN: US74340E1038)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.36
31.14
52 wk Range
16.10
31.36
PGNY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.3631.14
52 wk Range
16.1031.36
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PGNY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
30.09
Downside
-1.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Form 13G Progyny For: 8 June
- Investing.com
- Progyny stock hits 52-week high at 28.76 USD
- Investing.com
- Form 4 Progyny Inc For: 23 June
- Investing.com
- Progyny stock hits 52-week high at 31.07 USD
- Investing.com
- Progyny stock hits 52-week high at 28.76 USD
- Investing.com
- Form 4 Progyny Inc For: 23 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 30.09
(-1.82% Downside)
Progyny Inc SWOT Analysis
Market Dominance | Progyny leads the expanding fertility benefits market, projecting revenue of $1.185-$1.235 billion for 2025 amid strong client growth and service adoption. |
Financial Health | Explore Progyny's robust financials, including a 3.34 health score, strong cash flow yields, and a clean balance sheet primed for future growth. |
Analyst Perspectives | Delve into varied analyst views, with price targets ranging from $21 to $30, reflecting cautious optimism about Progyny's market position and growth potential. |
Strategic Expansion | Learn how Progyny's new offerings in maternity and menopause care, alongside payor partnerships, could significantly boost annual revenue by 2028. |
Progyny Inc Earnings Call Summary for Q1/2026
- Progyny Q1 2026 EPS of $0.29 beat forecast of $0.26; revenue of $328.5M exceeded estimates by 0.59%, up 1.4% YoY despite 1.44% stock decline
- Company completed $200M share repurchase program; gross margins expanded significantly through operational efficiencies
- Q2 2026 revenue guidance set at $342M-$355M, projecting 2.7%-6.6% growth with continued platform investment focus
- Executives emphasized strong member engagement and platform expansion while acknowledging macroeconomic pressures and competitive challenges
Last Updated: 2026-05-07, 09:54 p/m
Read Full TranscriptEarnings
Latest Release
May 07, 2026
EPS / Forecast
0.50 / 0.26
Revenue / Forecast
328.5M / 326.57M
Compare PGNY to Peers and Sector
Metrics to compare | PGNY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPGNYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 35.5x | −3.5x | −0.4x | |
PEG Ratio | 1.02 | 0.50 | 0.00 | |
Price/Book | 5.5x | 3.4x | 2.6x | |
Price / LTM Sales | 1.9x | 1.5x | 3.0x | |
Upside (Analyst Target) | −2.1% | 0.9% | 51.5% | |
Fair Value Upside | Unlock | 12.0% | 8.8% | Unlock |
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Progyny (PGNY) Stock Price Today?
The Progyny stock price today is 30.65 USD.
What Stock Exchange Does Progyny Trade On?
Progyny is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Progyny?
The stock symbol for Progyny is "PGNY."
What Is the Progyny Market Cap?
As of today, Progyny market cap is 2.40B USD.
What Is Progyny's Earnings Per Share (TTM)?
The Progyny EPS (TTM) is 0.76.
When Is the Next Progyny Earnings Date?
Progyny will release its next earnings report on Jul 30, 2026.
From a Technical Analysis Perspective, Is PGNY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Progyny Stock Split?
Progyny has split 0 times.
How Many Employees Does Progyny Have?
Progyny has 846 employees.
What is the current trading status of Progyny (PGNY)?
As of Jul 11, 2026, Progyny (PGNY) is trading at a price of 30.65 USD, with a previous close of 31.07 USD. The stock has fluctuated within a day range of 30.36 USD to 31.14 USD, while its 52-week range spans from 16.10 USD to 31.36 USD.
What Is Progyny (PGNY) Price Target According to Analysts?
The average 12-month price target for Progyny is 30.09 USD, with a high estimate of 33 USD and a low estimate of 27 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -1.82% Downside potential.
What Is the PGNY Premarket Price?
PGNY's last pre-market stock price is 31.62 USD. The pre-market share volume is 60.00, and the stock has decreased by 0.55, or 1.77%.
What Is the PGNY After Hours Price?
PGNY's last after hours stock price is 31.05 USD, the stock has decreased by 0.40, or 1.31%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.